Medtronic PLC Schedule 13G passive stakes

Medtronic plc has filed a Schedule 13G reporting beneficial ownership of 90% of the outstanding common stock of MiniMed Group, Inc.

Vanguard Capital Management has disclosed beneficial ownership of 96,424,044 shares, representing 7.51% of Medtronic PLC's common stock as of March 31, 2026.

The Vanguard Group has filed an amended Schedule 13G, reporting 0% beneficial ownership in Medtronic PLC following an internal corporate realignment.

Medtronic plc and Covidien Group S.a.r.l. have jointly reported a beneficial ownership of 17.8% in Orchestra BioMed Holdings, Inc. common stock.

The Vanguard Group has filed an amendment to its Schedule 13G, reporting a beneficial ownership of 10.21% in Medtronic PLC common stock.

BlackRock, Inc. has filed an amended Schedule 13G, revealing its beneficial ownership of 6.9% of Medtronic plc's common stock as of March 31, 2025.

Medtronic plc and its subsidiary Covidien Group S.a.r.l. have disclosed a combined beneficial ownership of 15.4% in Orchestra BioMed Holdings, Inc., holding 5,868,916 shares of common stock as of December 31, 2024.